OxyContin wins 'abuse-deterrent' label, but FDA bans older generic forms

Three years after the FDA OK'd Purdue Pharma's reformulated version of its controlled-release oxycodone drug, OxyContin, the company won the coveted "abuse-deterrent" language in the medicine’s labeling.